COVID-19: Pfizer requests emergency use authorization for new vaccine

Brazil’s national drug regulator Anvisa received from the pharmaceutical company Pfizer the request for authorization for the emergency use of a second vaccine against COVID-19. The new vaccine is bivalent, that is, it acts against two strains of the virus. In this case, the vaccine consists of a mixture of the original strain, used in […]

Fonte